Acknowledgement
Supported by : Ministry of Health of China, National Key Basic Research and Development Foundation of China
References
- Akyurek, L. M., Nallamshetty, S., Aoki, K., San, H., Yang, Z. Y., et al. (2001) Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo. Mol. Ther. 3, 779–786
- Benedetti, S., Dimeco, F., Pollo, B., Cirenei, N., Colombo, B. M., et al. (1997) Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Hum. Gene Ther. 8, 1345-1353 https://doi.org/10.1089/hum.1997.8.11-1345
- Bilbao, R., Gerolami, R., Bralet, M. P., Qian, C., Tran, P. L., et al. (2000) Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model. Cancer Gene Ther. 7, 657-662 https://doi.org/10.1038/sj.cgt.7700175
- Bremner, K. H., Seymour, L. W., and Pouton, C. W. (2001) Harnessing nuclear localization pathways for transgene delivery. Curr. Opin. Mol. Ther. 3, 170–177
- Brunner, S., Sauer, T., Carotta, S., Cotton, M., Saltik, M., et al. (2000) Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7, 401–407 https://doi.org/10.1038/sj.gt.3301102
- Chen, S. H., Kosai, K., Xu, B., Pham-Nguyen, K., Contant, C., et al. (1996) Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res. 56, 3758-3762
- Danthinne, X., Aoki, K., Kurachi, A. L., Nabel, G. J., and Nabel, E. G. (1998) Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicity. J. Virol. 72, 9201–9207
- Estin, D., Li, M., Spray, D., and Wu, J. K. (1999) Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy. Neurosurgery 44, 361–369 https://doi.org/10.1097/00006123-199902000-00068
- Gentry, B. G., Im, M., Boucher, P. D., Ruch, R. J., and Shewach, D. S. (2005) GCV phosphates are transferred between HeLa cells despite lack of bystander cytotoxicity. Gene Ther. 12, 1033-1041 https://doi.org/10.1038/sj.gt.3302487
- Gerolami, R., Uch, R., Brechot, C., Mannoni, P., and Bagnis, C. (2003) Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact. Cancer Gene Ther. 10, 649-660 https://doi.org/10.1038/sj.cgt.7700610
- Gorlich, D. and Kutay, U. (1999) Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15, 607–660 https://doi.org/10.1146/annurev.cellbio.15.1.607
- Goto, T., Nishi, T., Kobayashi, O., Tamura, T., Dev, S. B., et al. (2004) Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo. Mol. Ther. 10, 929-937 https://doi.org/10.1016/j.ymthe.2004.07.028
- Kamiya, H., Tsuchiya, H., Yamazaki, J., and Harashima, H. (2001) Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv. Drug Deliv. Rev. 52, 153-164 https://doi.org/10.1016/S0169-409X(01)00216-2
- Kokoris, M. S., Sabo, P., Adman, E. T., and Black, M. E. (1999) Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Ther. 6, 1415-1426 https://doi.org/10.1038/sj.gt.3300966
- Kokoris, M. S., Sabo, P., and Black, M. E. (2000) In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy. Anticancer Res. 20, 959–963
- Marconi, P., Tamura, M., Moriuchi, S., Krisky, D. M., Niranjan, A., et al. (2000) Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Mol. Ther. 1, 71-81 https://doi.org/10.1006/mthe.1999.0008
- McNeish, I. A., Tenev, T., Bell, S., Marani, M., Vassaux, G., et al. (2001) Herpes simplex virus thymidine kinase/ganciclovir- induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells. Cancer Gene Ther. 8, 308-319 https://doi.org/10.1038/sj.cgt.7700305
- Merilainen, O., Hakkarainen, T., Wahlfors, T., Pellinen, R., and Wahlfors, J. (2005) HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion construct. Int. J. Oncol. 27, 203-208
- Mohr, L., Yeung, A., Aloman, C., Wittrup, D., and Wands, J. R. (2004) Antibody-directed therapy for human hepatocellular carcinoma. Gastroenterology 127, S225-231 https://doi.org/10.1053/j.gastro.2004.09.037
- Okuda, K. (2000) Hepatocellular carcinoma. J. Hepatol. 32, 225–237
- O'Malley, B. W., Cope, K. A., Chen, S. H., Li, D., Schwarta, M. R., et al. (1996) Combination gene therapy for oral cancer in a murine model. Cancer Res. 56, 1737–1741
- Patterson, A. V., Saunders, M. P., and Greco, O. (2003) Prodrugs in genetic chemoradiotherapy. Curr. Pharm. Des. 9, 2131-2154 https://doi.org/10.2174/1381612033454117
- Qian, C., Bilbao, R., Bruna, O., and Prieto, J. (1995) Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 22, 118-123
- Ren, W., Strube, R., Zhang, X., Chen, S. Y., and Huang, X. F. (2004) Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine. Cancer Res. 64, 6645-6651 https://doi.org/10.1158/0008-5472.CAN-04-1084
- Rexach, M. and Blobel, G. (1995) Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell 83, 683–692 https://doi.org/10.1016/0092-8674(95)90181-7
- Ruiz, J., Mazzolini, G., Sangro, B., Qian, C., and Prieto, J. (2001) Gene therapy of hepatocellular carcinoma. Dig Dis. 19, 324–332 https://doi.org/10.1159/000050699
- Sachs, M. S., Selker, E. U., Lin, B., Roberts, C. J., Luo, Z., et al. (1997) Expression of herpes virus thymidine kinase in Neurospora crassa. Nucleic Acids Res. 25, 2389–2395 https://doi.org/10.1093/nar/25.12.2389
- Sa Cunha, A., Bonte, E., Dubois, S., Chretien, Y., Eraiser, T., et al. (2002) Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment. J. Hepatol. 37, 222–230 https://doi.org/10.1016/S0168-8278(02)00111-3
- Schwarze, S. R. and Dowdy, S. F. (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21, 45–48
- Stefani, A. L., Barzon, L., Castagliuolo, I., Guido, M., Pacenti, M., et al. (2005) Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J. Hepatol. 42, 728-735 https://doi.org/10.1016/j.jhep.2004.12.037
- Su, H., Lu, R., Ding, R., and Kan, Y. W. (2000) Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/ interleukin 2 is more effective in tumor killing in nonganciclovir (GCV)-treated than in GCV-treated animals. Mol. Ther. 1, 509-515 https://doi.org/10.1006/mthe.2000.0073
- Tanaka, M., Fraizer, G. C., De La Cerda, J., Cristiano, R. J., Liebert, M., et al. (2001) Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery. Gene Ther. 8, 139–148 https://doi.org/10.1038/sj.gt.3301367
- Tasciotti, E., Zoppe, M., and Giacca, M. (2003) Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat. Cancer Gene Ther. 10, 64-74 https://doi.org/10.1038/sj.cgt.7700526
- Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-6017 https://doi.org/10.1074/jbc.272.25.16010
- Wadia, J. S. and Dowdy, S. F. (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Deliv. Rev. 57, 579-596 https://doi.org/10.1016/j.addr.2004.10.005